Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000899243-21-008055)

Filing Details

Accession Number:: 0000899243-21-008055
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-02-24 17:42:28
Reporting Period:: 2021-02-22

Accepted Time:: 2021-02-24 17:42:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1797336	Ayala Pharmaceuticals Inc.	AYLA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1647053	Roni Mamluk	Oppenheimer 4 Rehovot L3 7670104	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-02-22	15,200	$19.86	163,271	No	4	S	Direct
Common Stock	Disposition	2021-02-23	7,126	$17.89	156,145	No	4	S	Direct
Common Stock	Disposition	2021-02-24	10,800	$17.40	145,345	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan.